Sei Investments CO Kezar Life Sciences, Inc. Transaction History

Sei Investments CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$3.13 - $7.31 $17,825 - $41,630	-5,695 Reduced 16.44%	28,941 $90,000
Q4 2022 Feb 10, 2023	SELL	$6.39 - $8.8 $7,731 - $10,648	-1,210 Reduced 3.38%	34,636 $243,000
Q2 2022 Aug 15, 2022	SELL	$4.58 - $17.13 $27,425 - $102,574	-5,988 Reduced 14.31%	35,846 $296,000
Q1 2022 May 13, 2022	SELL	$12.3 - $18.33 $56,432 - $84,098	-4,588 Reduced 9.88%	41,834 $695,000
Q4 2021 Feb 14, 2022	BUY	$7.44 - $16.72 $345,379 - $776,175	46,422 New	46,422 $776,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.